Acceptance and Commitment Therapy for Chemsex
(ACT-for-chemse Trial)
NC
Overseen ByNicholas C Borgogna, PhD
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.
Eligibility Criteria
This trial is for males aged 18-65 living in Alabama who have engaged in chemsex within the last six months, can speak English fluently, and have access to a smart device and private space for therapy sessions. It excludes those with recent self-harm or suicide attempts, severe mental health conditions like psychosis or bipolar disorder, major neurocognitive disorders, eating disorders, or those currently receiving similar ACT-based therapy.Inclusion Criteria
I am male.
Access to internet capable smart device
I have a private space for telehealth sessions.
See 3 more
Exclusion Criteria
Self-harm or suicide attempt within 12 months of screener
Suicide plan/intention at time of screening
I am currently receiving treatment for a serious health condition.
See 5 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Intake Session
Participants undergo an intake session before starting therapy
1 week
1 visit (in-person)
Treatment
Participants receive 16 weeks of Acceptance and Commitment Therapy (ACT) to reduce chemsex
16 weeks
16 visits (in-person)
Follow-up
Participants are monitored for safety and effectiveness after treatment
6 months
Multiple assessments (in-person and virtual)
Treatment Details
Interventions
- ACT-for-chemsex
Trial Overview The study tests acceptance and commitment therapy (ACT) specifically designed for individuals engaging in chemsex compared to the usual treatment methods. Participants are quasi-randomly assigned to receive either specialized ACT sessions via telehealth or continue with their standard care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: ACT-for-chemsexExperimental Treatment1 Intervention
16 weeks of ACT to reduce chemsex
Group II: Treatment as usualActive Control1 Intervention
Treatment as usual
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Trials
1,677
Recruited
2,458,000+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.